Cervical cancer screening in Sweden

被引：53

作者：

Dillner, J ^{[1
]}

机构：

[1] Karolinska Inst, Ctr Microbiol & Tumor Biol, MTC, S-17177 Stockholm, Sweden

来源：

EUROPEAN JOURNAL OF CANCER | 2000年 / 36卷 / 17期

关键词：

Sweden; cervical cancer screening; organised; opportunistic; human papilloma virus;

D O I：

10.1016/S0959-8049(00)00320-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Organised cervical cancer screening was implemented in Sweden in the mid-1960s. A marked decline in cervical cancer incidence could be attributed to the time-point of start of screening. Squamous cell carcinoma has declined by 60%, whereas adenocarcinoma has increased. About 950000 papanicolaou (Pap) smears are taken annually. Only 31% of the smears taken in the organised screening programme. As of 1998, the screening guidelines are 3-yearly tests between 23 and 50 years of age and 5-yearly tests between 50 and 60 yt als of age. The article reviews the screening practise in Sweden, the current efforts to improve the quality of the screening programme. as well as: the ongoing randomised evaluations of organised primary screening for cervical human papilloma virus (HPV) infection. (C) 2000 Elsevier Science Ltd. All rights reserved.

引用

页码：2255 / 2259

页数：5

共 10 条

[1] HUMAN PAPILLOMAVIRUS TESTING IN PRIMARY CERVICAL SCREENING [J].

CUZICK, J ;

SZAREWSKI, A ;

TERRY, G ;

HO, L ;

HANBY, A ;

MADDOX, P ;

ANDERSON, M ;

KOCJAN, G ;

STEELE, ST ;

GUILLEBAUD, J .

LANCET, 1995, 345 (8964) :1533-1536

[2] COMPARISON OF A ONE-STEP AND A 2-STEP POLYMERASE CHAIN-REACTION WITH DEGENERATE GENERAL PRIMERS IN A POPULATION-BASED STUDY OF HUMAN PAPILLOMAVIRUS INFECTION IN YOUNG SWEDISH WOMEN [J].

EVANDER, M ;

EDLUND, K ;

BODEN, E ;

GUSTAFSSON, A ;

JONSSON, M ;

KARLSSON, R ;

RYLANDER, E ;

WADELL, G .

JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (04) :987-992

[3] EFFICIENCY OF ORGANIZED AND OPPORTUNISTIC CYTOLOGICAL SCREENING FOR CANCER IN-SITU OF THE CERVIX [J].

GUSTAFSSON, L ;

SPAREN, P ;

GUSTAFSSON, M ;

WILANDER, E ;

BERGSTROM, R ;

ADAMI, HO .

BRITISH JOURNAL OF CANCER, 1995, 72 (02) :498-505

[4]

Hristova L, 1997, ACTA ONCOL, V36, P1

[5] A general primer GP5+/GP6+-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings [J].

Jacobs, MV ;

Snijders, PJF ;

vandenBrule, AJC ;

Helmerhorst, TJM ;

Meijer, CJLM ;

Walboomers, JMM .

JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (03) :791-795

[6] PAP SMEAR SCREENING AND CHANGES IN CERVICAL-CANCER MORTALITY IN SWEDEN [J].

MAHLCK, CG ;

JONSSON, H ;

LENNER, P .

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1994, 44 (03) :267-272

[7]

Nieminen P, 1999, INT J CANCER, V83, P55, DOI 10.1002/(SICI)1097-0215(19990924)83:1<55::AID-IJC11>3.0.CO

[8]

2-U

[9]

*SOS, 1998, GYN CELLPR FORSL SCR

[10] Present evidence on the value of HPV testing for cervical cancer screening: A model-based exploration of the (cost-)effectiveness [J].

vanBallegooijen, M ;

vandenAkkervanMarle, ME ;

Warmerdam, PG ;

Meijer, CJLM ;

Walboomers, JMM ;

Habbema, JDF .

BRITISH JOURNAL OF CANCER, 1997, 76 (05) :651-657

← 1 →